Interventional Pulmonology: Extending the Breadth of Thoracic Care
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-050922-060929. Online ahead of print.ABSTRACTInterventional pulmonary medicine has developed as a subspecialty focused on the management of patients with complex thoracic disease. Leveraging minimally invasive techniques, interventional pulmonologists diagnose and treat pathologies that previously required more invasive options such as surgery. By mitigating procedural risk, interventional pulmonologists have extended the reach of care to a wider pool of vulnerable patients who require therapy. Endoscopic innovations, including endobronchial ultrasound and robotic and ele...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Yaron B Gesthalter Colleen L Channick Source Type: research
Precision Approaches to Chronic Obstructive Pulmonary Disease Management
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-060622-101239. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD heterogeneity has hampered progress in developing pharmacotherapies that affect disease progression. This issue can be addressed by precision medicine approaches, which focus on understanding an individual's disease risk, and tailoring management based on pathobiology, environmental exposures, and psychosocial issues. There is an urgent need to identify COPD patients at high risk for poor outcomes and to understand at a me...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Matthew Moll Edwin K Silverman Source Type: research
Novel Therapeutic and Program-Based Approaches to Opioid Use Disorders
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-050522-033924. Online ahead of print.ABSTRACTOpioid use disorder continues to drive overdose deaths in many countries, including the United States. Illicit fentanyl and its analogues have emerged as key contributors to the complications and mortality associated with opioid use disorder. Medications for opioid use disorder treatment, such as methadone and buprenorphine, are safe and substantially reduce opioid use, infectious complications, and mortality risk, but remain underutilized. Polysubstance use and emerging substances such as xylazine and designer benzodiazepines ...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Patricia Liu P Todd Korthuis Bradley M Buchheit Source Type: research
Interventional Pulmonology: Extending the Breadth of Thoracic Care
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-050922-060929. Online ahead of print.ABSTRACTInterventional pulmonary medicine has developed as a subspecialty focused on the management of patients with complex thoracic disease. Leveraging minimally invasive techniques, interventional pulmonologists diagnose and treat pathologies that previously required more invasive options such as surgery. By mitigating procedural risk, interventional pulmonologists have extended the reach of care to a wider pool of vulnerable patients who require therapy. Endoscopic innovations, including endobronchial ultrasound and robotic and ele...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Yaron B Gesthalter Colleen L Channick Source Type: research
Precision Approaches to Chronic Obstructive Pulmonary Disease Management
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-060622-101239. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD heterogeneity has hampered progress in developing pharmacotherapies that affect disease progression. This issue can be addressed by precision medicine approaches, which focus on understanding an individual's disease risk, and tailoring management based on pathobiology, environmental exposures, and psychosocial issues. There is an urgent need to identify COPD patients at high risk for poor outcomes and to understand at a me...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Matthew Moll Edwin K Silverman Source Type: research
Novel Therapeutic and Program-Based Approaches to Opioid Use Disorders
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-050522-033924. Online ahead of print.ABSTRACTOpioid use disorder continues to drive overdose deaths in many countries, including the United States. Illicit fentanyl and its analogues have emerged as key contributors to the complications and mortality associated with opioid use disorder. Medications for opioid use disorder treatment, such as methadone and buprenorphine, are safe and substantially reduce opioid use, infectious complications, and mortality risk, but remain underutilized. Polysubstance use and emerging substances such as xylazine and designer benzodiazepines ...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Patricia Liu P Todd Korthuis Bradley M Buchheit Source Type: research
Interventional Pulmonology: Extending the Breadth of Thoracic Care
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-050922-060929. Online ahead of print.ABSTRACTInterventional pulmonary medicine has developed as a subspecialty focused on the management of patients with complex thoracic disease. Leveraging minimally invasive techniques, interventional pulmonologists diagnose and treat pathologies that previously required more invasive options such as surgery. By mitigating procedural risk, interventional pulmonologists have extended the reach of care to a wider pool of vulnerable patients who require therapy. Endoscopic innovations, including endobronchial ultrasound and robotic and ele...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Yaron B Gesthalter Colleen L Channick Source Type: research
Precision Approaches to Chronic Obstructive Pulmonary Disease Management
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-060622-101239. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD heterogeneity has hampered progress in developing pharmacotherapies that affect disease progression. This issue can be addressed by precision medicine approaches, which focus on understanding an individual's disease risk, and tailoring management based on pathobiology, environmental exposures, and psychosocial issues. There is an urgent need to identify COPD patients at high risk for poor outcomes and to understand at a me...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Matthew Moll Edwin K Silverman Source Type: research
Novel Therapeutic and Program-Based Approaches to Opioid Use Disorders
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-050522-033924. Online ahead of print.ABSTRACTOpioid use disorder continues to drive overdose deaths in many countries, including the United States. Illicit fentanyl and its analogues have emerged as key contributors to the complications and mortality associated with opioid use disorder. Medications for opioid use disorder treatment, such as methadone and buprenorphine, are safe and substantially reduce opioid use, infectious complications, and mortality risk, but remain underutilized. Polysubstance use and emerging substances such as xylazine and designer benzodiazepines ...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Patricia Liu P Todd Korthuis Bradley M Buchheit Source Type: research
Interventional Pulmonology: Extending the Breadth of Thoracic Care
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-050922-060929. Online ahead of print.ABSTRACTInterventional pulmonary medicine has developed as a subspecialty focused on the management of patients with complex thoracic disease. Leveraging minimally invasive techniques, interventional pulmonologists diagnose and treat pathologies that previously required more invasive options such as surgery. By mitigating procedural risk, interventional pulmonologists have extended the reach of care to a wider pool of vulnerable patients who require therapy. Endoscopic innovations, including endobronchial ultrasound and robotic and ele...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Yaron B Gesthalter Colleen L Channick Source Type: research
Precision Approaches to Chronic Obstructive Pulmonary Disease Management
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-060622-101239. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD heterogeneity has hampered progress in developing pharmacotherapies that affect disease progression. This issue can be addressed by precision medicine approaches, which focus on understanding an individual's disease risk, and tailoring management based on pathobiology, environmental exposures, and psychosocial issues. There is an urgent need to identify COPD patients at high risk for poor outcomes and to understand at a me...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Matthew Moll Edwin K Silverman Source Type: research
Novel Therapeutic and Program-Based Approaches to Opioid Use Disorders
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-050522-033924. Online ahead of print.ABSTRACTOpioid use disorder continues to drive overdose deaths in many countries, including the United States. Illicit fentanyl and its analogues have emerged as key contributors to the complications and mortality associated with opioid use disorder. Medications for opioid use disorder treatment, such as methadone and buprenorphine, are safe and substantially reduce opioid use, infectious complications, and mortality risk, but remain underutilized. Polysubstance use and emerging substances such as xylazine and designer benzodiazepines ...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Patricia Liu P Todd Korthuis Bradley M Buchheit Source Type: research
Interventional Pulmonology: Extending the Breadth of Thoracic Care
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-050922-060929. Online ahead of print.ABSTRACTInterventional pulmonary medicine has developed as a subspecialty focused on the management of patients with complex thoracic disease. Leveraging minimally invasive techniques, interventional pulmonologists diagnose and treat pathologies that previously required more invasive options such as surgery. By mitigating procedural risk, interventional pulmonologists have extended the reach of care to a wider pool of vulnerable patients who require therapy. Endoscopic innovations, including endobronchial ultrasound and robotic and ele...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Yaron B Gesthalter Colleen L Channick Source Type: research
Precision Approaches to Chronic Obstructive Pulmonary Disease Management
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-060622-101239. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD heterogeneity has hampered progress in developing pharmacotherapies that affect disease progression. This issue can be addressed by precision medicine approaches, which focus on understanding an individual's disease risk, and tailoring management based on pathobiology, environmental exposures, and psychosocial issues. There is an urgent need to identify COPD patients at high risk for poor outcomes and to understand at a me...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Matthew Moll Edwin K Silverman Source Type: research
Novel Therapeutic and Program-Based Approaches to Opioid Use Disorders
Annu Rev Med. 2023 Oct 12. doi: 10.1146/annurev-med-050522-033924. Online ahead of print.ABSTRACTOpioid use disorder continues to drive overdose deaths in many countries, including the United States. Illicit fentanyl and its analogues have emerged as key contributors to the complications and mortality associated with opioid use disorder. Medications for opioid use disorder treatment, such as methadone and buprenorphine, are safe and substantially reduce opioid use, infectious complications, and mortality risk, but remain underutilized. Polysubstance use and emerging substances such as xylazine and designer benzodiazepines ...
Source: Annual Review of Medicine - October 12, 2023 Category: General Medicine Authors: Patricia Liu P Todd Korthuis Bradley M Buchheit Source Type: research
